Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| CardioVascular Research Foundation, Korea | OTHER |
| Biotronik Korea Co., Ltd | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate effectiveness and safety of Orsiro™ Drug Eluting Stent in Routine Clinical Practice
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Orsiro™ Drug Eluting Stent |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Orsiro™ Drug Eluting Stent group | Device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Composite event rate | 1YEAR |
| Measure | Description | Time Frame |
|---|---|---|
| ALL DEATH | 5YEAR | |
| CARDIAC DEATH | 5YEAR | |
| MYOCARDIAL INFARCTION |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
patients with Orsiro™ Drug Eluting Stent
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hallym University Sacred Heart Hospital | Anyang | South Korea | ||||
| Soon Chun Hyang University Hospital Bucheon |
This is not a publicly funded trial.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 5YEAR |
| Composite event of death or myocardial infarction | 5YEAR |
| Composite event of cardiac death or myocardial infarction | 5YEAR |
| Target Vessel revascularization | 5YEAR |
| Target Lesion revascularization | 5YEAR |
| Stent thrombosis | stent thrombosis as classified by an Academic Research Consortium | 5YEAR |
| Stroke | 5YEAR |
| Procedural success | defined as less than 30% residual stenosis at the completion of procedure without death or Q wave myocardial infarction or urgent revascularization participants will be followed for the duration of hospital stay, an expected average of 3days. | 3day |
| Bucheon-si |
| South Korea |
| Dankook University Hospital | Cheonan | South Korea |
| Soon Chun Hyang University Hospital Cheonan | Cheonan | South Korea |
| Gangwon National Univ. Hospital | Chuncheon | South Korea |
| Daegu Catholic University Medical Center | Daegu | South Korea |
| Keimyung University Dongsan Medical Center | Daegu | South Korea |
| The Catholic University of Korea, Daejeon ST. Mary's Hospital | Daejeon | South Korea |
| Gangneung Asan Hospital | Gangneung | South Korea |
| Chonnam National University Hospital | Gwangju | South Korea |
| Gachon University Gil Hospital | Incheon | South Korea |
| Inje University Pusan Paik Hospital | Pusan | South Korea |
| Pusan National University Yangsan Hospital | Pusan | South Korea |
| Asan Medical Center | Seoul | South Korea |
| Gangnam Severance Hospital | Seoul | South Korea |
| Kangdong Sacred Heart Hospital | Seoul | South Korea |
| Korea University Guro Hospital | Seoul | South Korea |
| Ulsan University Hospital | Ulsan | South Korea |
| ID | Term |
|---|---|
| D003324 | Coronary Artery Disease |
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided